However, some other human and animal studies showed lower levels of adipsin in type 2 diabetes [85], thus suggesting that this adipokine could increase insulin sensitivity and diminish glucose intolerance in patients with diabetes by its ability to enhance insulin secretion via C3a production. Here, CFD is linked to type 2 diabetes mellitus.